TourniTek

Tourniquets are proven to save lives by preventing lethal blood loss. However, by restricting blood flow for the prolonged time required to transport an injured patient from the field to a surgical facility for treatment, tourniquet use often results in disability or amputation.

-2 provisional patents filed -Awarded $1,500,000 contract from the U.S. military to fund R&D -Partnered with both the U.S. and Canadian military for field testing, user testing, and lab testing in a paid pilot study. -Military testing with TourniTek is scheduled to begin in mid-2020. -Active prototype -3 years of pre-clinical studies done